KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Interest Coverage Ratio (2019 - 2025)

Historic Interest Coverage Ratio for Royalty Pharma (RPRX) over the last 7 years, with Q4 2025 value amounting to 4.12.

  • Royalty Pharma's Interest Coverage Ratio fell 2497.86% to 4.12 in Q4 2025 from the same period last year, while for Dec 2025 it was 5.07, marking a year-over-year decrease of 1155.53%. This contributed to the annual value of 5.07 for FY2025, which is 1155.53% down from last year.
  • Per Royalty Pharma's latest filing, its Interest Coverage Ratio stood at 4.12 for Q4 2025, which was down 2497.86% from 5.37 recorded in Q3 2025.
  • Over the past 5 years, Royalty Pharma's Interest Coverage Ratio peaked at 19.9 during Q2 2021, and registered a low of 10.28 during Q4 2022.
  • For the 5-year period, Royalty Pharma's Interest Coverage Ratio averaged around 5.78, with its median value being 5.43 (2025).
  • As far as peak fluctuations go, Royalty Pharma's Interest Coverage Ratio crashed by 41473.06% in 2022, and later surged by 59075.96% in 2025.
  • Over the past 5 years, Royalty Pharma's Interest Coverage Ratio (Quarter) stood at 3.27 in 2021, then tumbled by 414.73% to 10.28 in 2022, then skyrocketed by 226.18% to 12.97 in 2023, then crashed by 57.61% to 5.5 in 2024, then decreased by 24.98% to 4.12 in 2025.
  • Its Interest Coverage Ratio stands at 4.12 for Q4 2025, versus 5.37 for Q3 2025 and 3.06 for Q2 2025.